Welcome to my weekly newsletter on the cannabis and psychedelics industries. Analysts and investors are always looking for “catalysts” that can boost stocks. And in the psychedelics space, with biotech-style companies researching pharmaceutical drug candidates, such events can be massive gamechangers.
Recent funding rounds for companies in the psychedelics space are renewing interest in their drug candidates to treat conditions like depression and PTSD.